(Reuters) - India's largest drugmaker Sun Pharmaceutical Industries
Net loss was 4.25 billion rupees ($66.19 million) in the three months ending June, compared with a profit of 20.34 billion rupees a year earlier, the Mumbai-based company said on Friday. http://bit.ly/2uMEuCp
Total revenue from operations fell nearly 25 percent to 62.09 billion rupees.
($1 = 64.2050 Indian rupees)
(Reporting by Tanvi Mehta in Bengaluru)
Disclaimer: No Business Standard Journalist was involved in creation of this content
